Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Aug 10, 2018
Finance
Missing the obvious
Aisling’s Seltzer on why women’s health is underserved and ripe for investment
Read More
BioCentury
|
Jun 22, 2018
Financial News
ObsEva raises $73M follow-on
Read More
BioCentury
|
Jun 20, 2018
Financial News
ObsEva raises $73M on heels of linzagolix data
Read More
BioCentury
|
Mar 23, 2018
Clinical News
ObsEva's nolasiban meets in Phase III to improve pregnancy rates
Read More
BioCentury
|
Mar 30, 2017
Clinical News
Nolasiban: Ph III IMPLANT2 started
Read More
BioCentury
|
Jan 27, 2017
Financial News
ObsEva dips after $96.8M IPO
Read More
BioCentury
|
Dec 30, 2016
Financial News
Jounce, ObsEva file for IPOs
Read More
BioCentury
|
Nov 4, 2016
Clinical News
Nolasiban: Ph II data
Read More
BioCentury
|
Feb 1, 2016
Clinical News
IX-01: Phase IIa data
Read More
BioCentury
|
Jul 13, 2015
Clinical News
OBE001: Phase II started
Read More
Items per page:
10
1 - 10 of 20